Arnold & Porter’s practice advises on complex product liability disputes, including MDLs, acting as lead and national counsel, shaping overall defense strategy, and serving as trial counsel. Anand Agneshwar, based in New York, co-leads the team alongside Daphne O’Connor and focuses on high-stakes pharma litigation, including claims involving OTC products alleged to cause cancer and blood thinner drugs associated with bleeding injuries. The team also has experience resolving long-running litigation without trial. In Washington DC, O’Connor concentrates on medical device litigation, where personal injury claims, challenges to FDA approval, and regulatory decision-making are involved. Also in New York, Arthur Brown advises on matters involving alleged kidney injuries linked to inhibitor medications and claims on the causation of rare but serious genital infections. Paige Sharpe, in DC, serves on defense steering committees in coordinated proceedings and, together with Daniel Pariser, handles matters involving alleged suppression of drug efficacy information, injuries associated with medical devices, and injectable products alleged to contribute to the development or aggravation of T-cell lymphoma.

The DLA Piper LLP (US) team advises pharma and medical device clients on complex product liability, mass tort, and class action defense across the US. The practice is led by Christopher Campbell, based in Atlanta, and Loren Brown, located in New York. Campbell focuses on global mass tort litigation involving contraceptives, implantable devices, consumer class actions over alleged labeling issues, and claims relating to drug safety and device use. Brown concentrates on obesity and diabetes medications as well as medical devices, focusing on vision-loss allegations. In Boston, Katie Insogna regularly acts as lead trial counsel across multiple jurisdictions, while Matthew Holian handles alleged carcinogen and economic-loss claims involving medications as well as allegations surrounding injectable contraceptives. Lucas Przymusinski in New York supports Brown on obesity and diabetes matters, including alleged gastrointestinal injuries and early-stage resolutions.

Goldman Ismail Tomaselli Brennan & Baum LLP’s practice, led by Tarek Ismail in Chicago, serves as lead trial counsel in cases involving alleged carcinogenic exposure, renal and bone injuries related to tenofovir-containing drugs, labeling disputes about blood clot risk, and claims of atypical femur fractures. Brian O’Donoghue acts as national counsel and co-lead in Roundup litigation, managing defense strategy and case resolution. Emma Ross, Shayna Cook, and Rami Fakhouri advise on contraceptive device cases involving alleged breakage and removal complications. Jennifer Greenblatt handles medical nutrition product litigation, including cases related to preterm nutritional products, and has presented arguments before the Judicial Panel on Multidistrict Litigation. Based in Dallas, Joe Tomaselli manages medical device litigation, including insulin pump defect claims. In Santa Monica, Ken Baum oversees national science and expert strategy, including GLP-1 and vaccine litigation.

Greenberg Traurig’s practice is led by a trio of seasoned litigators, Lori Cohen, Sara Thompson, and Gregory Ostfeld, who serve as trial, settlement, and national counsel across high-profile litigation, providing ‘strategic, creative approaches to defending cases’. Based in Atlanta, Cohen serves as national trial and coordinating counsel on high-profile product liability matters, including hernia and pelvic mesh claims, vaccine-related personal injury, and medical devices such as pain management products. Thompson, also in Atlanta, handles MDL and recall litigation involving medical devices and over-the-counter medications, including phenylephrine-related claims, proton pump inhibitor drugs, kidney injuries, and dermatologic injuries from surgical devices, such as skin irritation and burns. Ostfeld, in Chicago, focuses on opioid litigation, defective MRI machines allegedly causing permanent hearing damage, devices producing inaccurate readings for patients with darker skin tones, battery explosions causing vision injuries, and class actions over allegedly deceptive marketing and warranty claims tied to recalls. Supporting the team, Victoria Lockard, based in Atlana assists on medical device and pharmaceutical recalls, as well as hernia and pelvic mesh matters.

The team at Kirkland & Ellis LLP handles complex disputes involving alleged personal injury and economic loss arising from drug and medical device products. The practice represents manufacturers in putative class actions and MDLs, with experience addressing failure-to-warn allegations, product labeling and disclosure issues, and claims tied to marketing and pricing practices. James Hurst, based in Chicago, focuses on matters involving alleged gastrointestinal injuries, including claims concerning infant formula, GLP-1 medications, and HIV drugs, as well as allegations of delayed introduction of alternative therapies. In New York, Jay Lefkowitz concentrates on prescription and over-the-counter drug litigation involving alleged mislabeling, ingredient disclosures, and marketing conduct, including claims asserting links between acne treatments and cancer. Allison Brown, based in Philadelphia, brings experience across MDLs involving both personal injury and economic loss, while Kim Bueno, based in Austin, serves as trial counsel in medical device litigation, including pelvic mesh matters. Mike Brock, based in Washington DC, is also a key member of the team, contributing to the team’s work in this area.

Based in Washington DC, the team at Williams & Connolly LLP handles complex disputes involving drug and medical device products, with a focus on MDLs, coordinated proceedings, and high-stakes trial work. Heidi Hubbard and Joseph Petrosinelli jointly lead the practice. Hubbard serves as trial and national counsel in MDLs and individual actions, including matters alleging inadequate warnings of permanent hair loss associated with chemotherapy drugs and claims involving medications alleged to cause lung conditions. Petrosinelli focuses on product liability litigation involving prescription and over-the-counter medications, including MDLs alleging links between drugs and various cancers, hormonal therapies, and meningiomas, as well as claims involving sickle cell disease treatments. Neelum Wadhwani supports the team’s work in nationwide opioid litigation and has experience negotiating large-scale settlements.

Bowman and Brooke LLP’s practice focuses on defending drug and medical device manufacturers and insurers in complex product liability, mass tort, and MDL proceedings across the US. The team is led by Kim Schmid in Minneapolis and Randall Christian in Austin, who act as trial and national counsel and coordinate MDL defense strategy and case management. Schmid advises on claims involving alleged reproductive cancers linked to veterinary pharma products, contaminated human tissue biologics, and birth defects tied to procedural injuries. Christian focuses on claims alleging chronic disease from long-term medication use, opioid use disorder, and personal injury arising from medical procedures and implanted or replacement devices, including stroke, severe infection, and death. Adam Masin in New York is also a recommended member of the team, advising on related personal injury litigation.

Led by practice heads Alyson Jones and Caroline Walker, Butler Snow LLP‘s practice provides trial support, lead and national trial counsel, and frequently serves as national coordinating counsel in complex product liability and mass tort matters. Jones, based in Mississippi, acts as national counsel in MDLs and coordinated proceedings involving alleged inadequate labeling and failure-to-warn claims, including litigation concerning prenatal drug exposure, home colon cancer screening tests and reporting timelines, and hernia mesh devices. Walker, based in Birmingham, serves as national counsel in the Paragard MDL, which alleged that the IUD had a propensity to fracture upon removal and cause complications, and has experience supporting mass tort settlements. Kari Sutherland, also based in Mississippi, focuses on MDL litigation involving pelvic mesh and other medical devices. Taylor Mayes, also based in Tennessee, contributes experience in wrongful death professional liability litigation involving alleged drug interactions and dosing issues.

Led by a team of practice heads, including Amy Fiterman, Andrew Campbell, Christopher Dolan, and Traci McKee, Faegre Drinker Biddle & Reath LLP provides national counsel, trial support, and coordination for complex product liability, mass tort, and class action matters in the pharma and medical devices sectors. Fiterman, based in Minneapolis, handles hernia and pelvic mesh products allegedly containing material and design defects, including infection, chronic pain, and repeat surgeries, as well as bone matrix products linked to contamination. Campbell, based in Indianapolis, serves as national coordinating counsel in MDLs for metal medical devices, addressing alleged corrosion and surgical site infections, and acts as local liaison counsel for preventative medication claims in animals. McKee, based in Fort Myers, provides national counsel on medical device personal injury claims, while Andrea Roberts Pierson, based in Indianapolis, manages federal MDLs, including bellwether trials and case dismissals for hernia mesh and other allegedly defective devices.

Hughes Hubbard & Reed LLP is led by practice heads James C. Fitzpatrick and Charles Cohen and brings a strong cross-border and international dimension to complex product liability and mass tort litigation. Cohen represents clients in wrongful death claims involving immunotherapy medicines, including district court allegations centered on failure-to-warn theories. Cohen and Fitzpatrick jointly handle federal MDL litigation arising from vaccination claims, including allegations of Postural Orthostatic Tachycardia Syndrome and Primary Ovarian Insufficiency, as well as personal injury suits involving alleged severe side effects, including loss of fertility, depression, and suicide. Bill Beausoleil focuses on medical device litigation for blood centers, including claims alleging infection of volunteer donors during the AIDS crisis, alongside other personal injury matters. Kevin Braker brings experience in pharma product liability and class action litigation, including claims involving pet medicines. The team is based in New York.

At King & Spalding, Andy Bayman and TaCara Harris, practice heads in Atlanta, handle Zantac litigation involving allegations that the drug caused bladder, kidney, and colorectal cancer, as well as complex medical device claims. Douglas Henderson, also in Atlanta, represents clients in mass tort cases involving life-saving medical devices and alleged ethylene oxide emissions from sterilization facilities, which plaintiffs claim caused cancer. Russell Gaudreau, in New York, leads strategic resolution efforts for hernia mesh and inferior vena cava filter MDLs. Susan Vargas, in Los Angeles, addresses claims of neuropsychiatric disorders from prescription medications, including failure-to-warn and negligence claims arising from generic substitutes. Val Leppert, in Miami, serves as national and trial counsel for surgically implantable medical devices, defending against allegations of negligence, design defect, and failure to warn, including complex trial and multi-jurisdictional matters.

Julie Park, in San Diego, and Katie Viggiani, in New York, co-lead Morrison Foerster’s product liability team, overseeing complex national matters across pharmaceuticals, medical devices, and healthcare services. Park handles retail pharmacy claims alleging in utero exposure to a drug caused children to develop autism spectrum disorder and ADHD. Park and Erin Bosman serve as lead counsel in MDLs alleging permanent hair loss and eye injuries from treatment with a generic docetaxel product, as well as nationwide product liability matters involving hip and knee replacement components allegedly causing serious injuries, revision surgeries, and ongoing pain. Alexandra Barlow assists in coordinating national medical device defense strategies, while Viggiani handles product liability claims involving defective online healthcare portals and over-the-counter drugs sold through e-commerce platforms.

At Nelson Mullins Riley & Scarborough LLP, Richard B. North, based in Atlanta, handles cases involving alleged over-infusion of infants using infusion pumps, including claims of severe anoxic brain injuries. North also serves as national coordinating counsel in IVC filter MDLs and atherectomy device claims, including wrongful death allegations. Terri Reiskin, in Washington DC, serves as co-lead counsel in the Birmingham hip resurfacing MDL, defending metal-on-metal implants allegedly misrepresented to doctors and patients, causing metallosis, pain, and revision surgeries. In Columbia, David Dukes manages MDL failure-to-warn claims for pharmaceutical providers. Kate Helm addresses alleged manufacturing defects in retractable needles and syringes, serves as national counsel for defective PET scan machines, and co-leads cases involving implantable cardiac devices allegedly failing to prevent medical events.

High-value, high-profile disputes define O'Melveny’s work in the pharma and medical device space. Practice heads Steve Brody, in Washington DC, and Sabrina Strong, in Los Angeles, steer complex, multi-jurisdictional litigation strategies. Strong is closely involved in GLP-1 drug litigation and advises on legal communications and risk management concerning counterfeit and compounded versions of branded products. Brody focuses on mass tort and MDL proceedings, including pelvic mesh litigation alleging personal injury and consumer protection violations, as well as opioid cases brought by third-party payors and neonatal abstinence syndrome plaintiffs. Hannah Chanoine, in New York, serves as lead counsel to a drug manufacturer in an MDL concerning allegations of ineffectiveness. In San Francisco, Amy Laurendeau represents clients in product liability matters involving catastrophic injuries and wrongful death claims tied to prescription medications, medical devices, and over-the-counter pain relievers alleged to cause severe adverse skin reactions.

Melissa Geist leads Reed Smith LLP’s team from Princeton, overseeing coordinated national defense strategies in high-stakes medical device litigation. Geist serves as co-national coordinating and trial counsel in pelvic mesh MDL proceedings involving alleged personal injury mass tort claims and acts as national counsel in implant litigation centered on failure-to-warn allegations. Also in Princeton, Julia Lopez focuses on pharmaceutical disputes, serving as strategic counsel in an MDL arising from a product recall and related personal injury complaints, including claims involving mislabeled bottles and GLP-1 drugs alleged to cause gastrointestinal injuries. In Philadelphia, Stephen McConnell acts as lead counsel in an MDL concerning over-the-counter stomach acid medication and defends wrongful death claims alleging manufacturing defects in heart pump devices. Julie Hardin, in Houston, handles personal injury litigation arising from surgical procedures. Michael Brown retired in 2025.

John Beisner, based in Washington DC, leads Skadden, Arps, Slate, Meagher & Flom LLP’s team in complex pharmaceutical, healthcare, and technology-related litigation. In Washington DC, Milli Kanani Hansen serves as counsel in an MDL alleging personal injuries and economic losses from high blood pressure medications claimed to be contaminated with trace amounts of a potential carcinogen. In New York, Michael McTigue represents retail pharmacies in connection with a threatened mass arbitration regarding the marketing and sale of certain oral decongestant products. Richard Bernardo, also in New York, advises a cloud-based software company in a False Claims Act matter concerning its electronic health records software, addressing alleged security vulnerabilities and failures to comply with federal regulatory requirements.

Troutman Pepper Locke LLP is active in complex pharmaceutical and medical device litigation spanning MDLs, coordinated proceedings, and individual high-exposure claims. Ronni Fuchs, in Princeton, leads defense efforts in litigation alleging contamination of generic metformin. Sean Fahey, based in Philadelphia, serves as lead and liaison counsel for brand manufacturers in federal MDLs, including cases involving heater-cooler systems used in open-heart surgery that are alleged to have caused non-tuberculous mycobacterial infections. Fuchs and Fahey also act as coordinating counsel in personal injury matters alleging that specialized infant formula caused serious gastrointestinal disease and that ethylene oxide used to sterilize medical devices resulted in cancer. Both individuals lead the team. In Philadelphia, Hyung Steele handles opioid MDL personal injury actions involving allegations of developmental disabilities in children, while Barry Boise, also in Philadelphia, represents clients in litigation arising from clinical trials allegedly causing significant injuries.

Handling a broad range of coordinated national matters, Venable LLP represents clients in complex, high-exposure litigation. Kathleen Hardway and Jason Rose direct multi-jurisdictional defense efforts. Hardway serves as national counsel in vaccine litigation alleging shingles, vision loss, cardiac events, and neurological injuries associated with live-virus products. Craig Thompson acts as national or co-national counsel in cases involving acid reflux medications allegedly causing kidney injuries, prenatal genetic testing errors, prescriptions linked to mental health conditions and suicidal ideation, and claims arising from alleged drug misfills at grocery chain pharmacies. Dino Sangiamo serves as co-national counsel in MDL proceedings alleging vaccines caused POTS and autoimmune conditions, including negligence and failure-to-warn claims and alleged nondisclosure during the FDA approval process. Rachele Sokolis assists in MDLs and personal injury matters involving both medications and medical devices. All are based in Baltimore.

The team at Dechert handles coordinated MDL and state court mass tort litigation across multiple jurisdictions, including matters alleging that a heartburn medication formed NDMA and caused cancer. The practice is led by Jay Bhimani in Los Angeles, alongside Mark Cheffo and Douglas Fleming in New York, who oversee strategy and coordination in large-scale proceedings. Sheila Birnbaum, also based in New York and recently re-joined after retirement, focuses on claims alleging personal injury or economic loss arising from medication-related crises and regularly serves as national counsel in federal MDLs and parallel state court actions involving significant damages. Cheffo also brings experience as lead defense counsel for GlaxoSmithKline in pharmaceutical litigation, supporting clients through complex discovery, expert challenges, and trial preparation in mass tort disputes.

Samuel Tarry, based in Washington DC, is a practice head at McGuireWoods LLP and represents clients in class actions alleging deceptive marketing, inadequate product warnings, and the targeting of minors. In Richmond, Davis Walsh and Candace Blydenburgh defend product liability claims involving a colonoscope allegedly defectively designed and causing colon damage. Tarry, Walsh, and Blydenburgh also serve as national product liability counsel in matters arising from patient injuries linked to reprocessed medical devices used in hospitals, advising on regulatory reporting and settlement strategy. In Raleigh, Mark Anderson handles claims alleging defective design, manufacture, and warnings for surgical anchor devices. The team also assists clients in jurisdictional proceedings involving diagnostic testing kits.

Heidi Levine, in New York, and Jennifer Saulino, in Washington DC, lead the Sidley Austin LLP complex pharmaceutical litigation. Saulino serves as lead trial counsel in cases alleging fraud, including claims that a hemophilia drug manufacturer engaged in kickback schemes and promoted the medication for off-label uses. Levine sits on the trial team in an MDL concerning a heartburn medication, defending false advertising, failure-to-warn, and related claims tied to the alleged presence of a carcinogenic chemical. In Chicago, Michelle Ramirez handles common-law fraud claims arising from a discontinued program that repackaged oncology products into pre-filled syringes. The team was further strengthened by Paul Boehm‘s arrival in Washington DC, in December 2025.

Sherry A. Knutson in Chicago and Tariq Naeem in Cleveland, Ohio, lead Tucker Ellis LLP’s life sciences litigation practice, with a focus on high-exposure product liability and class action litigation. Knutson serves as trial counsel in cases alleging infant formula caused gastrointestinal disease and neurological injuries, including cerebral palsy and bacterial meningitis, and in litigation involving allegedly defective hernia and pelvic mesh devices resulting in permanent injuries, with assistance from Charissa Walker, based in Cleveland. Knutson also handles medical device claims involving alleged kidney damage. In Cleveland, Jennifer Mesko defends class actions alleging consumer fraud based on the failure to disclose harmful metals in infant formula. Connor Doughty in Chicago assists in litigation concerning medical treatments allegedly causing permanent alopecia and eye injuries, including claims involving blocked tear ducts.

Sandra Edwards in San Francisco leads Winston Taylor’s team. In Chicago, Bryce Cooper serves as co-trial counsel in an MDL alleging that preterm infant formula caused gastrointestinal disorders in premature infants. Christopher Essig acts as national counsel for a drug manufacturer in opioid litigation, defending claims including negligence, fraud, and violations of consumer protection laws. Steve D’Amore handles cases involving alleged heavy metals and other contaminants in infant formula. Both also are based in Chicago. The team combines national coordination with trial experience to manage complex product liability and mass tort matters across pharmaceuticals and medical devices. Dan Webb, in Chicago, is also recommended.